This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Syngenta And Bayer CropScience Propose A Comprehensive Action Plan To Help Unlock EU Stalemate On Bee Health

Stocks in this article: SYT

In further detail, the key features of the action plan are:

Significantly scale up the provision of pollen rich flowering field margins across the EU to be sown alongside bee attractive crops treated with neonicotinoids to provide habitat and nutrition.

  • This would build on Syngenta's 10-year Operation Pollinator program which has demonstrated that these margins dramatically increase pollinator populations, including honeybees.
  • This would address one of the main factors identified by the European Commission in the decline in bee health.

Support for the establishment of a comprehensive field monitoring program for bee health including the detection of crop protection chemicals

  • A comprehensive program, following the guidelines for surveillance projects by the EU Reference Laboratory for honey bee health, shall be established.
  • The current monitoring work of the EU reference laboratories on bee health, supported by national bee institutes, should be reinforced and extended.
  • Within this new scope the detection of chemicals from crop protection, particularly neonicotinoids, and veterinary products should be included.

Mandatory implementation of strict measures to mitigate the exposure risk to bees

  • High quality treatment of seed to take place only in certified production sites which participate in a Quality Assurance Scheme.
  • Strict rules governing the use of treated seed, such as the mandatory use of deflectors in planting machinery, application only by professional and certified users, and improved information exchange between farmers and beekeepers.
  • Bayer Crop Science recently developed "SweepAir", a new air-cleaning technology for maize sowing equipment offering a significant improvement in comparison to standard technology; first field tests with the prototype indicate a dust reduction well above 95%. 

Invest in and roll out new technologies which further reduce the dust emissions from the planting of seed treated with neonicotinoid crop protection chemicals

  • Bayer CropScience and Syngenta are both working on new solutions to further improve the coating of seeds treated with crop protection chemicals and the way they are planted to ensure that dust emissions are minimized.
  • Some of these solutions are ready to be deployed and we commit to continuing our investment in the research and development of these risk mitigation measures.

Further invest in the research and development of new solutions for the main factors impacting bee health

  • The European Commission identifies disease and viruses such as Varroa destructor, American foulbrood, European foulbrood, Nosema spp., and honey bee viruses as the main cause of the decline in bee health.
  • Bayer CropScience and Syngenta have both invested in the research and development of new solutions to these parasites, diseases and viruses and commit to stepping up our activities in this area.
  • Bayer CropScience and Syngenta commit to supporting area-wide long-term pilot studies which demonstrate their effectiveness.

Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to http://www.syngenta.com

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions.Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements.We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties.Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

Syngenta International AG Media Office CH-4002 Basel Switzerland Tel:    +41-61-323-2323 Fax:    +41-61-323-2424 Media contacts: Paul Barrett Switzerland    +41-61-323 2323     Daniel Braxton Switzerland    +41-61-323-2323 Analyst/Investor contacts: Jennifer Gough Switzerland    +41-61-323-5059 USA    +1-202-737-6521 Lars Oestergaard Switzerland    +41-61-323-6793 USA    +1-202-737-6520 http://www.syngenta.com

SOURCE Syngenta Crop Protection AG

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs